Intraventricular Tuberculoma of the Central Nervous System: A Systematic Review of Clinical Presentation, Management, and Outcome
10 affiliations
- 1Research Department of SAFNA, Cotonou, Benin
- 2Department of Neurosurgery, Teaching Hospital of Fann, Cheikh Anta Diop University, Dakar, Senegal
- 3Department of Neurosurgery, Military and Teaching Hospital of Parakou, Parakou, Benin
- 4Department of Neurosurgery, Teaching Hospital of Bouaké, Bouaké, Ivory Coast
- 5Department of Neurosurgery, Sylvanus Olympio Teaching Hospital, Lomé, Togo
- 6Laboratory of Human Anatomy, Faculty of Medicine, Félix Houphouët-Boigny University, Abidjan, Ivory Coast
- 7Department of Neurosurgery, Teaching Hospital of Yopougon, Abidjan, Ivory Coast
- 8Department of Neurosurgery, CHU CAEN Normandie, Caen, France
- 9Imaging Brain and Neuropsychiatry iBraiN U1253, INSERM, Université De Tours, Tours, France
- 10Department of Neurosurgery, Université De Tours, Tours, France
Abstract
BACKGROUND AND OBJECTIVES:: Tuberculosis remains a major global health burden, with central nervous system (CNS) involvement accounting for 1% to 10% of cases. Intraventricular tuberculoma is a distinct, poorly documented entity, separate from tuberculous meningitis with hydrocephalus. This systematic review assessed the epidemiology, diagnosis, management, and outcomes of CNS intraventricular tuberculoma.
METHODS:: PubMed and Scopus were searched per Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines for studies on CNS intraventricular tuberculoma (PROSPERO registration number CRD420251017978). Pooled data were summarized using measures of central tendency and dispersion.
RESULTS:: Of 841 records identified, 18 studies (17 case reports, 1 retrospective series) encompassing 30 patients were included. Patients were predominantly male (53.3%), with a median age of 24 years [IQR 11.5-31.8]. The median symptom duration before admission was 3 months [IQR 2-4]; headache (76.7%) and fever (66.7%) were the most common presenting symptoms. MRI was performed in 73.3% and computed tomography in 46.7% of cases. Hydrocephalus was present in 53.3% at diagnosis, and the tuberculoma was most often located in the lateral ventricle (46.7%). Antituberculous therapy alone was used in 56.7% of patients, while 43.3% received combined medical-surgical treatment; among the 13 patients treated surgically, microsurgical resection achieved gross total removal in 9 (69.2%). The median follow-up was 15.5 months [IQR 7.5-26.3], with favorable outcomes in 76.7% and mortality of 3.3%.
CONCLUSION:: Intraventricular tuberculoma is a rare, distinct manifestation of CNS tuberculosis strongly associated with hydrocephalus. Prompt recognition and individualized medical-surgical management are associated with favorable outcomes, although evidence remains limited to case-level reports, warranting confirmation through prospective, multicenter studies.
Related
- Marburg Virus Disease (MVD): a rapid systematic review with narrative synthesis of epidemiology, clinical presentation, diagnostics, management, and public-health response.
- Clinical presentation and management patterns of ureteral calculi in pregnancy: a 14-year single-institution retrospective study
- IL-17 Inhibitor-Associated New Onset Inflammatory Bowel Disease: Clinical Presentation and Management: A Report of Two Cases
- Clinical Characteristics and Management of Pediatric Facial Wounds with Documented Infection or Delayed Presentation: A 25-Year Retrospective Case Series
- Rare adipose disorders: a review of clinical presentation, pathophysiology, and management with illustrative case series.
BibTeX
@article{gbenou2026intraventricular,
title = {{Intraventricular Tuberculoma of the Central Nervous System: A Systematic Review of Clinical Presentation, Management, and Outcome}},
author = {Férol Baudelaire Babatundé Gbenou and Yao Christian Hugues Dokponou and Dzidoula Late Lawson and Nicaise Kpegnon Agada and Omar Boladji Adebayo Badirou and Raïssa Diaby and Nourou Dine Adeniran Bankole},
journal = {Neurosurgery Practice},
year = {2026},
month = nov,
doi = {10.1227/neuprac.0000000000000320},
url = {https://doi.org/10.1227/neuprac.0000000000000320},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Intraventricular Tuberculoma of the Central Nervous System: A Systematic Review of Clinical Presentation, Management, and Outcome
AU - Férol Baudelaire Babatundé Gbenou
AU - Yao Christian Hugues Dokponou
AU - Dzidoula Late Lawson
AU - Nicaise Kpegnon Agada
AU - Omar Boladji Adebayo Badirou
AU - Raïssa Diaby
AU - Nourou Dine Adeniran Bankole
PY - 2026
DA - 2026/11/05
JO - Neurosurgery Practice
DO - 10.1227/neuprac.0000000000000320
UR - https://doi.org/10.1227/neuprac.0000000000000320
AB - BACKGROUND AND OBJECTIVES:: Tuberculosis remains a major global health burden, with central nervous system (CNS) involvement accounting for 1% to 10% of cases. Intraventricular tuberculoma is a distinct, poorly documented entity, separate from tuberculous meningitis with hydrocephalus. This systematic review assessed the epidemiology, diagnosis, management, and outcomes of CNS intraventricular tuberculoma. METHODS:: PubMed and Scopus were searched per Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines for studies on CNS intraventricular tuberculoma (PROSPERO registration number CRD420251017978). Pooled data were summarized using measures of central tendency and dispersion. RESULTS:: Of 841 records identified, 18 studies (17 case reports, 1 retrospective series) encompassing 30 patients were included. Patients were predominantly male (53.3%), with a median age of 24 years [IQR 11.5-31.8]. The median symptom duration before admission was 3 months [IQR 2-4]; headache (76.7%) and fever (66.7%) were the most common presenting symptoms. MRI was performed in 73.3% and computed tomography in 46.7% of cases. Hydrocephalus was present in 53.3% at diagnosis, and the tuberculoma was most often located in the lateral ventricle (46.7%). Antituberculous therapy alone was used in 56.7% of patients, while 43.3% received combined medical-surgical treatment; among the 13 patients treated surgically, microsurgical resection achieved gross total removal in 9 (69.2%). The median follow-up was 15.5 months [IQR 7.5-26.3], with favorable outcomes in 76.7% and mortality of 3.3%. CONCLUSION:: Intraventricular tuberculoma is a rare, distinct manifestation of CNS tuberculosis strongly associated with hydrocephalus. Prompt recognition and individualized medical-surgical management are associated with favorable outcomes, although evidence remains limited to case-level reports, warranting confirmation through prospective, multicenter studies.
SN - 2834-4383
ER -